SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-23-138863
Filing Date
2023-05-09
Accepted
2023-05-09 06:51:22
Documents
56
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d431523d10q.htm   iXBRL 10-Q 607507
2 EX-31.1 d431523dex311.htm EX-31.1 10736
3 EX-31.2 d431523dex312.htm EX-31.2 10696
4 EX-32.1 d431523dex321.htm EX-32.1 5876
  Complete submission text file 0001193125-23-138863.txt   3529818

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA mdgl-20230331.xsd EX-101.SCH 32899
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mdgl-20230331_cal.xml EX-101.CAL 28793
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mdgl-20230331_def.xml EX-101.DEF 133671
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdgl-20230331_lab.xml EX-101.LAB 280145
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdgl-20230331_pre.xml EX-101.PRE 225412
50 EXTRACTED XBRL INSTANCE DOCUMENT d431523d10q_htm.xml XML 420476
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33277 | Film No.: 23899859
SIC: 2834 Pharmaceutical Preparations